Bitcoin has fallen 44.9% from its all-time high recorded on October 6, 2025, echoing past bear markets where prices dropped over 75% and took 10-13 months to bottom. Historical trends show that buying after a 45% drop often leads to further losses within a year, but dollar-cost averaging since the peak has reduced losses to just 11.6%. Investors are advised to avoid lump-sum buys during sharp declines and consider spreading purchases over time or using staggered buy orders. The market's future direction remains uncertain, with a potential bottom ranging from $19,300 to $29,200 if past deep bear patterns repeat, but recovery timing is unclear.
Bitcoin's recent crash provides context for cryptocurrency market activity on Pluang as of Nov 14, 2026 00:41 WIB. Among 50 major cryptocurrencies, 20 rose while 29 fell today. Notably, BAL gained 11.14% to Rp16.297 with a typical hold time of 85 days, contrasting with GRT which rose 7.11% to Rp330 but saw a heavy sell bias at 93% sell orders, and EOS increased 8.13% to Rp12.649 with a hold time of 87 days.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
